LIVN News and Press, LivaNova PLC From 09/30/22

The U.S. Food and Drug Administration (FDA) on Friday classified the recall of several hundred blood bypass pump systems by LivaNova ( NASDAQ: LIVN ) as the most serious type. LivaNova ( LIVN ) in July recalled 484 LifeSPARC Systems in the U.S. distributed between Dec....

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third-quarter 2022 results on Wednesday, November 2, 2022, at 12 p.m. London time (8 a.m. EDT). The Company will release its third-quarter 2022 results pri...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the LivaNova Board of Directors appointed Brooke Story to the Board, effective September 15, 2022. In addition, Story will be a member of the Nominating and Corporate Governa...

LivaNova PLC (LIVN) Q2 2022 Earnings Conference Call August 03, 2022, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO & Director Alex Shvartsburg - CFO Conference Call Participants Michael Polark - Wo...

The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q2 earnings call. For further details see: LivaNova PLC 2022 Q2 - Results - Earnings Call Presentation

LivaNova printed Q2 FY22 earnings this week with upsides in revenue and EPS versus consensus. Return on invested capital and FCF yield continue to sag low for the company dampening the investment debate. Valuations are also unsupportive as the stock trades at a premium to peers an...

LivaNova PLC press release ( NASDAQ: LIVN ): Q2 Non-GAAP EPS of $0.53 beats by $0.01 . Revenue of $254.2M (-3.9% Y/Y) beats by $4.65M . Updated Full-Year 2022 Outlook LivaNova now expects revenue for full-year 2022 to grow between 4 and 6 percent on a con...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2022. Financial Summary and Highlights 1 Revenue of $254.2 million for the quarter, decreased 3.9 percent on a reported ba...

Growth will not do great during a recession because the one thing that justifies their high multiples is growth, which they are less likely to achieve. Nonetheless, there are ways to play growth during a recession, which is find things that are self-financing to avoid reflexivity risk...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its second-quarter 2022 results on Wednesday, August 3, 2022 at 1 p.m. London time (8 a.m. EDT). The Company will release its second-quarter 2022 results prior...